QCM
NVO

Quest Capital Management’s Novo Nordisk NVO Stock Holding History

Quest Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$346K Sell
6,178
-218
-3% -$11.8K 0.06% 217
2021
Q3 		$307K Sell
6,396
-912
-12% -$44.1K 0.06% 219
2021
Q2 		$306K Buy
7,308
+598
+9% +$23.2K 0.06% 207
2021
Q1 		$226K Buy
+6,710
New +$239K 0.05% 240

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quest Capital Management's NVO Position: Q4 2021 in Review

Quest Capital Management reduced its Novo Nordisk (NVO) stake by 3.4% in Q4 2021, selling an estimated $11.8K and leaving 6,178 shares worth $346K. The position accounts for 0.06% of the portfolio, ranked #217.

Quest Capital Management first reported a position in NVO in Q1 2021 and has held it in 4 quarters since. 886 funds tracked by Wall St. Rank hold NVO as of Q4 2021.

  • Quest Capital Management held 6,178 shares of Novo Nordisk worth $346K as of Q4 2021.
  • Quest Capital Management sold 218 Novo Nordisk shares in Q4 2021, an estimated $11.8K.
  • Novo Nordisk made up 0.06% of Quest Capital Management's portfolio in Q4 2021, its #217 holding.
  • Quest Capital Management first reported a position in Novo Nordisk in Q1 2021 and has held it in 4 quarters since.
  • 886 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.